tiprankstipranks
Trending News
More News >
Silexion Therapeutics (SLXN)
NASDAQ:SLXN
US Market

Silexion Therapeutics (SLXN) Technical Analysis

Compare
157 Followers

Technical Sentiment

Overall Consensus
Sell
5Bullish
3Neutral
14Bearish
Technical Analysis Consensus
Buy
5Bullish
3Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Silexion Therapeutics’s (SLXN) Moving Averages Convergence Divergence (MACD) indicator is -0.01, suggesting Silexion Therapeutics is a Buy.
Silexion Therapeutics’s (SLXN) 20-Day exponential moving average is 0.94, while Silexion Therapeutics’s (SLXN) share price is $0.88, making it a Sell.
Silexion Therapeutics’s (SLXN) 50-Day exponential moving average is 1.03, while Silexion Therapeutics’s (SLXN) share price is $0.88, making it a Sell.

Silexion Therapeutics (SLXN) Pivot Points

Jun 14, 2025, 08:27 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.84
0.87
0.89
0.92
0.94
0.97
0.99
Fibonacci
0.87
0.89
0.90
0.92
0.94
0.95
0.97
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Silexion Therapeutics (SLXN) Moving Averages

Jun 14, 2025, 08:27 AM
Period
Simple
Exponential
MA5
0.92Sell
0.91Sell
MA10
0.94Sell
0.93Sell
MA20
0.95Sell
0.94Sell
MA50
0.92Sell
1.03Sell
MA100
1.07Sell
3.57Sell
MA200
2.67Sell
15.89Sell
Silexion Therapeutics’s (SLXN) 10-Day exponential moving average is 0.93, while Silexion Therapeutics’s (SLXN) share price is $0.88, making it a Sell.
Silexion Therapeutics’s (SLXN) 100-Day exponential moving average is 3.57, while Silexion Therapeutics’s (SLXN) share price is $0.88, making it a Sell.
Silexion Therapeutics’s (SLXN) stock price is $0.88 and Silexion Therapeutics’s (SLXN) 50-day simple moving average is 0.92, creating a Sell signal.
Silexion Therapeutics’s (SLXN) stock price is $0.88 and Silexion Therapeutics’s (SLXN) 100-day simple moving average is 1.07, creating a Sell signal.
Silexion Therapeutics’s (SLXN) stock price is $0.88 and Silexion Therapeutics’s (SLXN) 200-day simple moving average is 2.67, creating a Sell signal.

Silexion Therapeutics (SLXN) Technical Indicators

Jun 14, 2025, 08:27 AM
Name
Value
Implied Action
RSI (14)
41.51
Neutral
STOCH (9,6)
19.35
Buy
STOCHRSI (14)
25.00
Neutral
MACD (12,26)
-0.01
Buy
ADX (14)
17.63
Buy
Williams %R
-87.50
Buy
CCI (14)
-141.38
Buy
ATR (14)
0.08
-
Ultimate Oscillator
42.48
Neutral
ROC
-10.20
Sell
Silexion Therapeutics’s (SLXN) Relative Strength Index (RSI) is 41.51, creating a Neutral signal.
Silexion Therapeutics’s (SLXN) Trend Strength Indicator (ADX) is 17.63, creating a Buy signal.
Silexion Therapeutics’s (SLXN) Commodity Channel Index (CCI) is -141.38, creating a Buy signal.
Silexion Therapeutics’s (SLXN) Price Rate of Change (ROC) is -10.20, creating a Sell signal.

FAQ

Is SLXN a Buy, Hold, or Sell?
Based on SLXN’s technical indicators, SLXN is a Sell.
    What is SLXN’s RSI (14)?
    SLXN’s RSI (14) is 41.51, which suggests SLXN is a Neutral.
      What is SLXN’s MACD?
      SLXN’s MACD is -0.01, which suggests SLXN is a Buy.
        What is SLXN’s 5-day moving average?
        SLXN’s 5-day moving average is 0.92, which suggests SLXN is a Sell.
          What is SLXN’s 20-day moving average?
          SLXN 20-day moving average is 0.95, which suggests SLXN is a Sell.
            What is SLXN’s 50-day moving average?
            SLXN’s 50-day moving average is 0.92, which suggests SLXN is a Sell.
              What is SLXN’s 200-day moving average?
              SLXN’s 200-day moving average is 2.67, which suggests SLXN is a Sell.
                What is SLXN’s Williams % R (14)?
                SLXN’s Williams % R (14) is -87.50, which suggests SLXN is a Buy.
                  What is SLXN’s CCI (14)?
                  SLXN’s CCI (14) is -141.38, which suggests SLXN is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis